Longer Breastfeeding in Infancy, Better School Grades for Kids?
TUESDAY, June 6, 2023 -- Could breastfeeding lay the groundwork for good grades in high school?
That ' s what the findings of a new British study suggest, although the differences were small between those who were breastfed and those who weren ' t when... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 6, 2023 Category: General Medicine Source Type: news
Breastfeeding beyond one year linked to higher test scores, study says
Researchers have found the longer babies are breastfed, the better they perform on standardized assessment tests as adolescents, according to a study published Monday in the Archives of Disease in Childhood. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 6, 2023 Category: Consumer Health News Source Type: news
Kids breastfed for at least year are 38% more likely to get As in exams, study finds
The study, involving almost 5,000 children in England, found those breastfed for at least four months were around 12 per cent more likely than non-breastfed children to pass at least five GCSEs. (Source: the Mail online | Health)
Source: the Mail online | Health - June 5, 2023 Category: Consumer Health News Source Type: news
When Do Congenital Dermal Melanocytosis Lesions Resolve?
This study also had 1 patient with superimposed skin findings. This has been reported in other studies.
Questions for Further Discussion
1. What are common skin lesions for major phakomatoses? A review can be found here
2. When is jaundice abnormal? Additional cases can be reviewed here
3. What is the natural history of capillary hemangiomas?
Related Cases
Disease: Congenital Dermal Melanocytosis or Mongolian Spots | Skin Pigmentation Disorders
Symptom/Presentation: Pigmentary Lesions
Specialty: Dermatology
Age: Newborn
To Learn More
To view pediatric review articles on this topic from the past year check PubMed.
Evidence-...
Source: PediatricEducation.org - June 5, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
What Sub-Saharan African Nations Can Teach the U.S. About Black Maternal Health
While poor maternal outcomes among Black women in the U.S. is not new, improving it is imperative. U.S. policymakers can look to sub-Saharan Africa for guidance on reversing this trend. Credit: Ernest Ankomah/IPSBy Ifeanyi NsoforABUJA, Jun 2 2023 (IPS) New research shows that Black mothers in the United States disproportionately live in counties with higher maternal vulnerability and face greater risk of preterm death for the fetus, greater risk of low birth weight for a baby, and a higher number of maternal deaths.
While poor maternal outcomes among Black women in the U.S. is not new, improving it is imperative. U.S. poli...
Source: IPS Inter Press Service - Health - June 2, 2023 Category: International Medicine & Public Health Authors: Ifeanyi Nsofor Tags: Africa Gender Headlines Health Inequality North America Poverty & SDGs Maternal Health Source Type: news
I'm a mom - here's why I give my 12-year-old breast milk
Mothers have countless reasons to breastfeed their children beyond babyhood, but many feel publicly shamed into stopping. North Carolina mom Priscilla Morton is still nursing her 4 year old. (Source: the Mail online | Health)
Source: the Mail online | Health - June 1, 2023 Category: Consumer Health News Source Type: news
TREMFYA ® (guselkumab) Provides Sustained Improvements Across All Minimal Disease Activity Domains for Adults Living with Active Psoriatic Arthritis in Phase 3b Trial
SPRING HOUSE, PENNSYLVANIA, May 31, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 3b COSMOS clinical trial showing that treatment with TREMFYA® (guselkumab) provided sustainable improvements in all minimal disease activity (MDA)a domains through week 48 in adults living with active psoriatic arthritis (PsA) who previously had an inadequate response to one to two tumor necrosis factor inhibitors (TNFi-IR).[1] In a separate post-hoc analysis of the Phase 3 DISCOVER-1 and DISCOVER-2b clinical trial findings, TREMFYA was shown to be associated with prompt and su...
Source: Johnson and Johnson - May 31, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Investigational Single Tablet Combination Therapy of Macitentan and Tadalafil for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
RARITAN, NJ, May 30, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of an investigational single tablet combination therapy of macitentan 10mg and tadalafil 40mg (M/T STCT) for the long-term treatment of pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1) in adult patients with WHO functional class (FC) II-III.[1] The application is based on positive data from the Phase 3 A DUE study, which met its primary endpoint and demonstrated that M/T STCT si...
Source: Johnson and Johnson - May 30, 2023 Category: Pharmaceuticals Source Type: news
Prolonged breastfeeding and dental caries in preschool children
Conclusion:
Breastfeeding up to 18 months of age was not associated with caries development during preschool age. (Source: Dental Technology Blog)
Source: Dental Technology Blog - May 24, 2023 Category: Dentistry Source Type: news
New Moms Breastfed Longer During Pandemic
New research shows new moms tended to breastfeed their babies about two weeks longer than usual during the shelter-in-place period early in the COVID pandemic. (Source: WebMD Health)
Source: WebMD Health - May 22, 2023 Category: Consumer Health News Source Type: news
New Moms Breastfed Longer During Pandemic
MONDAY, May 22, 2023 -- Early in the COVID-19 pandemic, when shelter-in-place orders were ongoing, new moms tended to breastfeed their babies about two weeks longer than usual, new research shows. “Stay-at-home policies enabled parents to continue... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 22, 2023 Category: General Medicine Source Type: news
All The Stuff in Your Home That Might Contain PFAS ‘ Forever Chemicals ’
If you put on a pair of soft contact lenses this morning you took a greater risk than you might realize. Soft lenses seem very eye-friendly; they’re smooth, comfortable, allow oxygen to reach the eye and, if they’re disposable, they don’t give bacteria any time to grow. What’s not to like? Well, one very important thing, actually.
According to tests commissioned by the consumer watchdog site Mamavation and the green group Environmental Health News, a random sampling of 18 popular brands of soft lenses sent to an Environmental Protection Agency (EPA)-certified lab all tested positive for PFAS, short ...
Source: TIME: Health - May 19, 2023 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized Environment Explainer healthscienceclimate Source Type: news
How Healthy Is a Vegan Mom's Breast Milk?
WEDNESDAY, May 17, 2023 -- Vegan moms can breastfeed their children and not worry that their breast milk is missing essential nutrients, a new study finds.
Researchers from Amsterdam University Medical Center in the Netherlands tested the milk of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 17, 2023 Category: General Medicine Source Type: news
I'm a fertility doctor - these are the 5 biggest myths about getting pregnant
Advice like lying down after sex to increase your chances and myths that it is impossible to get pregnant while breastfeeding can make it hard to separate fact from fiction. (Source: the Mail online | Health)
Source: the Mail online | Health - May 16, 2023 Category: Consumer Health News Source Type: news
First Phase 3 TREMFYA ® (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction Results Among Patients with Moderately to Severely Active Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, May 9, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new efficacy and safety data from the Phase 3 QUASAR Induction Study evaluating the investigational use of TREMFYA® (guselkumab) in adults with moderately to severely active ulcerative colitis (UC)a who had an inadequate response or intolerance to conventionalb and/or advanced therapies.1,c The data show statistically significant and clinically meaningful improvements across symptomatic and histo-endoscopic outcome measures.1 Safety data were also consistent with the known safety profile of TREMFYA in ...
Source: Johnson and Johnson - May 9, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
